Vetbiolix is a veterinary biotech developing first-in-class therapeutics for pets. Targeting Osteoarthritis, Periodontitis & Gut Motility in dogs and cats.
Investors 2
| Date | Name | Website |
| - | Exponion | exponion.c... |
| 10.07.2026 | Band of An... | bandangels... |
Mentions in press and media 1
| Date | Title | Description |
| 15.04.2024 | Medivir’s partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701 | Medivir’s partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701 Mon, Apr 15, 2024 13:40 CET Report this content Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical ... |